MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (finance)
- RELIGARE ENT
RELIGARE ENT Share Price 
(RELIG)
Here is the latest stock price and chart of RELIGARE ENT. For more details, see the RELIGARE ENT company fact sheet and quarterly results. For a sector overview, read our finance sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
Discover: The 5-Minute Blueprint for Becoming a ONE STOCK CROREPATI
| Live BSE Quotes | Jul 7, 2022 12:37:00 PM | ||
|---|---|---|---|
| Price (Rs)124.30 | Open (Rs) 120.80 | High (Rs) 126.05 | Low (Rs) 120.30 |
| % Change3.89 | Volume 295,711 | Value (Rs) 36,756,877 | 52-Week H/L 194.50 / 97.65 |
| Live NSE Quotes | Jul 7, 2022 12:39:38 PM | ||
|---|---|---|---|
| Price (Rs)124.50 | Open (Rs) 120.75 | High (Rs) 126.00 | Low (Rs) 119.75 |
| % Change4.05 | Volume 559,716 | Value (Rs) 69,046,566 | 52-Week H/L 194.80 / 97.65 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day 3.89% | 1 Month -12.68% | 3 Months -7.27% | 1 Year -7.96% | 5 Years (CAGR)* -2.69% | 10 Years (CAGR)* -9.34% |
* Compound Annual Growth Rate
| Valuation | ||||
|---|---|---|---|---|
| EPS (Rs)* -48.19 | P/E Ratio (x) NM | Market Cap (Rs m) 39,678.71 | P/BV (x) -2.46 | Dividend Yield (%) 0.00 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX
PERIOD - Advanced Charts new
- Charts by TradingView
RELIGARE ENT Share Price Today:
RELIGARE ENT last traded price was up 3.9% to Rs 124.3 on the BSE. On the NSE, RELIGARE ENT last traded price was up 4.1% to Rs 124.5. The total volume of shares traded was 0.9 m.
Overall, the benchmark S&P BSE SENSEX was at 54,127.6 (up 0.7%).
Over the last 30 days, the RELIGARE ENT share price is down 7.3%. And over the last one year, RELIGARE ENT share price is down 10.2%.
The current market capitalisation of RELIGARE ENT stands at Rs 39,678.71 m. For more information, check out the list of top 100 companies in India in terms of market cap.
The promoters of RELIGARE ENT do not hold any stake in the company as of March 2022. To know who holds the largest chunk of shares, check out the latest shareholding pattern of RELIGARE ENT.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
FAQs on RELIGARE ENT
What is the RELIGARE ENT share price today?
The last traded price of RELIGARE ENT was Rs 124.3 on the BSE, up 3.9% over the previous close. On the NSE, RELIGARE ENT last traded price was up 4.1% at Rs 124.5.
What is the market cap of RELIGARE ENT?
The current market capitalisation of RELIGARE ENT stands at Rs 39,679 m.
What is the Earnings per share (EPS) of RELIGARE ENT?
RELIGARE ENT had an EPS of Rs -48.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -18.4.
What is the Dividend Yield of RELIGARE ENT?
For the financial year 2021, RELIGARE ENT declared dividend amounting to Rs 0.0 per share. At the current price of Rs 124.3, this results in a dividend yield of 0.0%.
Today's Market
Sensex Zooms 400 Points, Nifty Trades Above 16,000; Titan Rallies 6%(10:30 am)
Asian share markets mostly opened higher today after minutes from a Federal Reserve meeting showed that US central bankers are determined to fight inflation despite recession worries.
Related Views On News
6 Penny Stocks with Solid Growth and Zero Debt (Views On News)
Jul 1, 2022Penny stocks which have a decent balance sheet, low or zero debt and a track record for paying consistent dividend fare much better against their peers.
Why Did Saurabh Mukherjea Exit his Position in HDFC AMC? (Views On News)
Jun 23, 2022Fund manager Saurabh Mukherjea has exited this underperforming HDFC group stock. Find out why.
5 Consistent Compounding Stocks Available at Discount. Time to Buy? (Views On News)
Jun 22, 2022The good side of a market correction? Investors get consistent compounding stocks at a discount.
Why Indiabulls Housing Finance Share Price is Falling (Views On News)
May 18, 2022What are the key reasons behind the recent decline in Indiabulls Housing Finance stock? Read on to find out...
5 Takeaways from HDFC's Q4 Results (Views On News)
May 2, 2022The mortgage lender recorded its highest monthly individual disbursements ever in the March quarter.
More Views on NewsMost Popular
5 Indian Companies where Mutual Fund Holdings are Consistently Increasing (Views On News)
Jul 1, 2022Mutual funds are buying shares at a time when FIIs are consistently selling. Here are 5 stocks where MF holdings has increased for the past 4 quarters.
Auto Stocks are in the Fast Lane. Is it Time to Buy? (Profit Hunter)
Jun 23, 2022The auto index is outperforming the Nifty by a mile. Have auto stocks finally bottomed out?
Forget FIIs. Follow These Experts to Navigate the Market (Profit Hunter)
Jun 24, 2022How you deal with the recent correction is going to be a great differentiator in your net worth.
Why Crude Oil Price is Falling (Views On News)
Jun 25, 2022Global markets have become volatile, sending chills through the crude oil market.
The 4 Strongest Companies in the Tata Group. Add Them to Your Watchlist (Views On News)
Jun 30, 2022Check out these four Tata group companies that have the strongest performance and fundamentals.
MoreOUR TOP 5 IDEAS
TRACK RELIGARE ENT
- Track your investment in RELIGARE ENT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON RELIGARE ENT
RELIGARE ENT 8-QTR ANALYSIS
COMPARE RELIGARE ENT WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks in 2022
TRENDING TOPICS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.